Alexandra Drakaki MD
Genitourinary Oncology, Hematologic Oncology
Clinical Instructor, UCLA
Join to View Full Profile
2020 Santa Monica Blvd., Suite 600Santa Monica, CA 90404
Phone+1 310-829-5471
Fax+1 310-829-5471
Dr. Drakaki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
Tufts Medical CenterResidency, Internal Medicine, 2007 - 2010
University of Crete School of Health SciencesClass of 2006
Certifications & Licensure
CA State Medical License 2013 - 2027
MA State Medical License Active through 2013
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- FELLOWSHIP/ GI ASCO MERITT AWARD ASCO, 2013
Clinical Trials
- A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer Start of enrollment: 2015 Jul 13
Publications & Presentations
PubMed
- Molecular Diversity of Embryonic-Type Neuroectodermal Tumors Arising From Testicular Germ Cell Tumors.Yang Zong, Rongrong Huang, Mireille Bitar, Alexandra Drakaki, Liying Zhang
Modern Pathology. 2025-04-01 - NCCN Guidelines® Insights: Testicular Cancer, Version 2.2025.Timothy Gilligan, Daniel W Lin, Nabil Adra, Aditya Bagrodia, Darren R Feldman
Journal of the National Comprehensive Cancer Network. 2025-04-01 - Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study.Amin H Nassar, Sarah Abou Alaiwi, Talal El Zarif, Ryan Denu, Walid Macaron
Journal for Immunotherapy of Cancer. 2025-03-03
Authored Content
- Association of Baseline Systemic Corticosteroid Use with Overall Survival and Time to Next Treatment in Patients Receiving Immune Checkpoint Inhibitor Therapy in Real-World US Oncology Practice for Advanced Non-Small Cell Lung Cancer, Melanoma, or Urothelial CarcinomaJune 2020
Press Mentions
UCLA Investigators Highlight Innovations in Prostate and Bladder Cancer, AI, and Patient-Centered Care at Aua 2025April 22nd, 2025- UCLA Researchers Showcase Breakthroughs in Prostate and Bladder Cancer, AI Applications, and Patient-Centered Care at AUA 2025April 21st, 2025
- New Imaging Technique Accurately Detects Aggressive Kidney Cancer, Claims StudyOctober 21st, 2024
- Join now to see all
Grant Support
- Role of mir9 in liver oncogenesisUCLAPresent
Research History
- PhD/Identification of microRNA signature in liver oncogenesis2015 - Present
Other Languages
- Greek
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
